A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infectionTarek Hassanein, David Gardiner, Lynn R. Webster et al.|Journal of Hepatology|2015Cited by 53
Effects of the H <sub>2</sub> -Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected PatientsXiaodong Wang, Richard Bertz, Marta Boffito et al.|AIDS Patient Care and STDs|2011Cited by 18
Effects of the H 2 -Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected PatientsJenny Zhang, Yaoshi Wu, Xiaodong Wang et al.|UNC Libraries|2020Cited by 4